Loading company…
Toronto developer of cancer therapeutics that target the WDR5 protein, founded in 2016.
Propellon Therapeutics Inc. is based in Toronto, Canada, and was founded in 2016. It develops cancer therapeutics that target the WDR5 protein. The listed stage is Seed.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in